Galectin Therapeutics Inc files DEFA14A
- Filed on 2026-10-13
- Schedule 14A proxy statement
- Filed by the registrant
GALT
GALECTIN THERAPEUTICS INC SEC filings
Every EDGAR filing for GALECTIN THERAPEUTICS INC (GALT), newest first, with AI summaries and stories.
- Ticker
- GALT
- CIK
- 1133416
- Latest filing
- 6d
Next: earnings expected ~Nov 16 · 10-Q expected ~Nov 16 (deadline Nov 16)
Filings
Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.
ROUTINEDEFA14AGALECTIN THERAPEUTICS INCGALTLIVE ROUTINEARSGALECTIN THERAPEUTICS INCGALTLIVE Galectin Therapeutics Inc filed ARS on 2026-10-13.
- Filed ARS on 2026-10-13.
- Document size: 550 bytes.
- PDF version: 1.6.
ROUTINEDEF 14AGALECTIN THERAPEUTICS INCGALTLIVE Galectin Therapeutics holds 2026 annual meeting online
- Annual meeting on Dec 3, 2026, virtual only
- 11 directors to be elected
- Amendment to increase common stock from 150M to 250M shares
ROUTINEPRE 14AGALECTIN THERAPEUTICS INCGALTLIVE Galectin Therapeutics holds 2026 annual meeting online
- Annual meeting on Dec 3, 2026, virtual only
- Election of 11 directors
- Amendment to increase common stock from 150M to 250M
ROUTINE8-KGALECTIN THERAPEUTICS INCGALTLIVE NOTABLE10-QGALECTIN THERAPEUTICS INCGALTLIVE NOTABLESCHEDULE 13D/AGALECTIN THERAPEUTICS INCGALTLIVE Ownership stake disclosure by Richard E Uihlein (amended)
Richard E Uihlein, filed by
ROUTINE4GALECTIN THERAPEUTICS INCGALTLIVE Richard E Uihlein, insider filing for GALT
Richard E Uihlein, reporting
ROUTINE8-KGALECTIN THERAPEUTICS INCGALTLIVE ROUTINE4GALECTIN THERAPEUTICS INCGALTLIVE Khurram Jamil, insider filing for GALT
Khurram Jamil, reporting
ROUTINE4GALECTIN THERAPEUTICS INCGALTLIVE 2 insider filings
Harold H. Shlevin, insider filing for GALT
Show all 2
- 4Insider filing for GALT
- 4Insider filing for GALT
Harold H. Shlevin, reporting
ROUTINE144GALECTIN THERAPEUTICS INCGALTLIVE Harold H. Shlevin, planned sale of GALT shares
Harold H. Shlevin, reporting
ROUTINE144GALECTIN THERAPEUTICS INCGALTLIVE Khurram Jamil, planned sale of GALT shares
Khurram Jamil, reporting
ROUTINE144GALECTIN THERAPEUTICS INCGALTLIVE Harold H. Shlevin, planned sale of GALT shares
Harold H. Shlevin, reporting
ROUTINE4GALECTIN THERAPEUTICS INCGALTLIVE Khurram Jamil, insider filing for GALT
Khurram Jamil, reporting
ROUTINE144GALECTIN THERAPEUTICS INCGALTLIVE Khurram Jamil, planned sale of GALT shares
Khurram Jamil, reporting
ROUTINE8-KGALECTIN THERAPEUTICS INCGALTLIVE ROUTINE4GALECTIN THERAPEUTICS INCGALTLIVE Khurram Jamil, insider filing for GALT
Khurram Jamil, reporting
ROUTINE8-KGALECTIN THERAPEUTICS INCGALTLIVE NOTABLE10-QGALECTIN THERAPEUTICS INCGALTLIVE ROUTINEEFFECTGALECTIN THERAPEUTICS INCGALTLIVE ROUTINES-3GALECTIN THERAPEUTICS INCGALTLIVE ROUTINE8-KGALECTIN THERAPEUTICS INCGALTLIVE NOTABLE10-KGALECTIN THERAPEUTICS INCGALTLIVE ROUTINE4GALECTIN THERAPEUTICS INCGALTLIVE 2 insider filings
Henry Brem, insider filing for GALT
Show all 2
- 4Insider filing for GALT
- 3New insider at GALT
Henry Brem, reporting
ROUTINE8-KGALECTIN THERAPEUTICS INCGALTLIVE ROUTINE4GALECTIN THERAPEUTICS INCGALTLIVE Kary Eldred, insider filing for GALT
Kary Eldred, reporting
ROUTINE4/AGALECTIN THERAPEUTICS INCGALTLIVE Joel Lewis, insider filing for GALT (amended)
Joel Lewis, reporting
ROUTINE4GALECTIN THERAPEUTICS INCGALTLIVE 12 insider filings
Benjamin Carson Sr, insider filing for GALT
Show all 12
- 4Insider filing for GALT
- 4Insider filing for GALT
- 4Insider filing for GALT
- 4Insider filing for GALT
- 4Insider filing for GALT
- 4Insider filing for GALT
- 4Insider filing for GALT
- 4Insider filing for GALT
- 4Insider filing for GALT
- 4Insider filing for GALT
- 4Insider filing for GALT
- 4Insider filing for GALT
Benjamin Carson Sr, reporting
ROUTINE8-KGALECTIN THERAPEUTICS INCGALTLIVE ROUTINE4GALECTIN THERAPEUTICS INCGALTLIVE Joel Lewis, insider filing for GALT
Joel Lewis, reporting
ROUTINE8-KGALECTIN THERAPEUTICS INCGALTLIVE ROUTINE4GALECTIN THERAPEUTICS INCGALTLIVE 3 insider filings
Joel Lewis, insider filing for GALT
Show all 3
- 4Insider filing for GALT
- 4Insider filing for GALT
- 4Insider filing for GALT
Joel Lewis, reporting
ROUTINE144GALECTIN THERAPEUTICS INCGALTLIVE Harold H. Shlevin, planned sale of GALT shares
Harold H. Shlevin, reporting
ROUTINE144/AGALECTIN THERAPEUTICS INCGALTLIVE Jack W Callicutt, planned sale of GALT shares (amended)
Jack W Callicutt, reporting